Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macula... by Borchert, GA, Kiire, CA, Stone, NM, Akil, H, Gkika, T, Fischer, MD, Xue, K, Cehajic-Kapetanovic, J, MacLaren, RE, Charbel Issa, P, Downes, SM, De Silva, SR